Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases

Jian-Hui Su1,2, Meng-Yi Luo1,2, Na- Liang3

  • 1Institute of Clinical Research, Affiliated Nanhua Hospital, Hengyang Medical College, University of South China, Hengyang, China.

Frontiers in Pharmacology
|September 10, 2021
PubMed

Insights

Interleukin-6 (IL-6) drives inflammation and oxidative stress, contributing to cardio-cerebrovascular diseases like atherosclerosis and stroke. Targeting IL-6 offers a potential strategy for preventing and treating these serious conditions.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Immunology

Background:

  • Cardio-cerebrovascular diseases pose a significant global health threat.
  • Inflammatory factors are critical in determining vascular plaque stability and disease incidence.
  • Interleukin-6 (IL-6) is a key cytokine implicated in inflammation and oxidative stress.

Purpose of the Study:

  • To discuss the expression changes of IL-6 in cardio-cerebrovascular diseases.
  • To elucidate the pathological mechanisms involving IL-6 in these conditions.
  • To explore IL-6 as a potential therapeutic target for cardio-cerebrovascular diseases.

Main Methods:

  • Review of existing literature on IL-6 and cardio-cerebrovascular diseases.
  • Analysis of studies investigating IL-6 expression patterns.
  • Examination of molecular pathways linking IL-6 to cardiac and cerebral injury.

Main Results:

  • Increased IL-6 expression is strongly associated with atherosclerosis, myocardial infarction, heart failure, and ischemic stroke.
  • IL-6 acts as a risk factor by initiating inflammatory responses and inducing other detrimental molecules.
  • IL-6 contributes to cardiac and cerebral injury through inflammation and oxidative stress.

Conclusions:

  • IL-6 plays a pivotal role in the pathogenesis of cardio-cerebrovascular diseases.
  • Targeting IL-6 presents a promising avenue for novel prevention and treatment strategies.
  • Further research into IL-6 mechanisms could lead to significant clinical advancements.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
119
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
265
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
429
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.4K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
107